Augmenter of liver regeneration potentiates doxorubicin anticancer efficacy by reducing the expression of ABCB1 and ABCG2 in hepatocellular carcinoma
Augmenter of liver regeneration potentiates doxorubicin anticancer efficacy by reducing the expression of ABCB1 and ABCG2 in hepatocellular carcinoma
Laboratory Investigation 97,
1400 (December 2017). doi:10.1038/labinvest.2017.72
Authors: Yuan-yuan Guo, Yuan Wu, Xiao-wei Jia & Wei An
Source: Laboratory Investigation - Category: Laboratory Medicine Authors: Yuan-yuan Guo Yuan Wu Xiao-wei Jia Wei An Source Type: research
More News: Cancer & Oncology | Carcinoma | Hepatocellular Carcinoma | Laboratory Medicine | Liver | Liver Cancer | Urology & Nephrology